Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer
出版年份 2022 全文链接
标题
Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer
作者
关键词
-
出版物
ONCOGENE
Volume 41, Issue 37, Pages 4307-4317
出版商
Springer Science and Business Media LLC
发表日期
2022-08-19
DOI
10.1038/s41388-022-02437-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer
- (2022) Samikshan Dutta et al. ONCOGENE
- The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy
- (2021) Manlio Tolomeo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- WLS-Wnt signaling promotes neuroendocrine prostate cancer
- (2021) Tyler Bland et al. iScience
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains
- (2020) Amanda Khoury et al. Nature Communications
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The androgen receptor regulates a druggable translational regulon in advanced prostate cancer
- (2019) Yuzhen Liu et al. Science Translational Medicine
- Neuropilin‐2 Is An Independent Prognostic Factor For Shorter Cancer‐Specific Survival In Patients With Acinar Adenocarcinoma Of The Prostate
- (2019) A. Borkowetz et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
- (2019) Mark P. Labrecque et al. JOURNAL OF CLINICAL INVESTIGATION
- Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression
- (2018) Shancheng Ren et al. EUROPEAN UROLOGY
- Cellular plasticity and the neuroendocrine phenotype in prostate cancer
- (2018) Alastair H. Davies et al. Nature Reviews Urology
- AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer
- (2018) Hong ZHU et al. Theranostics
- Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories
- (2018) Clarissa Gerhauser et al. CANCER CELL
- Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality
- (2017) B W C Tse et al. ONCOGENE
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations
- (2016) Phillippa C. Taberlay et al. GENOME RESEARCH
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible
- (2016) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
- (2016) Jennifer L. Bishop et al. Cancer Discovery
- Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner
- (2016) Kevin J Tam et al. Oncotarget
- The Hitchhiker’s guide to Hi-C analysis: Practical guidelines
- (2015) Bryan R. Lajoie et al. METHODS
- Aggressive Variants of Castration-Resistant Prostate Cancer
- (2014) H. Beltran et al. CLINICAL CANCER RESEARCH
- Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis
- (2014) Hai Tao Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
- (2014) D Zhao et al. ONCOGENE
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- VEGF/Neuropilin-2 Regulation of Bmi-1 and Consequent Repression of IGF-IR Define a Novel Mechanism of Aggressive Prostate Cancer
- (2012) Hira Lal Goel et al. Cancer Discovery
- Multifaceted Role of Neuropilins in Cancer
- (2011) S. Rizzolio et al. CURRENT MEDICINAL CHEMISTRY
- PC3 is a cell line characteristic of prostatic small cell carcinoma
- (2011) Sheng Tai et al. PROSTATE
- Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes
- (2011) A. Aparicio et al. Cancer Discovery
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
- (2010) Xiaomei Ren et al. ACS Medicinal Chemistry Letters
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-binding Domain of Neuropilin-1
- (2008) Claudia Prahst et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver
- (2008) M. J. Gray et al. JNCI-Journal of the National Cancer Institute
- Regulation of Sox2 by STAT3 Initiates Commitment to the Neural Precursor Cell Fate
- (2008) Kara M. Foshay et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now